Clinical Trial Update: Allogeneic Stem Cell Transplantation (SCT) With Treosulfan, VP-16 and Cyclophosphamid for Patients With Acute Lymphoblastic Leukemia (ALL) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating allogeneic stem cell transplantation using treosulfan, etoposide (VP-16), and cyclophosphamide for acute lymphoblastic leukemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Etoposide (Etoposide)
• Treosulfan (treosulfan)

Snippet

Sponsor: Universitätsklinikum Hamburg-Eppendorf | Conditions: Acute Lymphoblastic Leukemia | Phase 2 | Status: COMPLETED